抗生素
微生物学
细胞毒性
抗菌剂
细菌
真菌
RNA聚合酶
生物
对接(动物)
聚酮
抗菌活性
化学
抗菌剂
酶
人类病原体
结构-活动关系
生物化学
核糖核酸
立体化学
结构相似性
聚合酶
分子模型
金黄色葡萄球菌
生物活性
聚酮合酶
作者
Zi-Peng Wang,Sijie Cheng,Ying Li,Chu-Hong Fang,Xiangyu Liu,Xiao-Ning Wang,Dongliang Guan,Jian‐Min Yue,Jin‐Hai Yu
标识
DOI:10.1021/acs.jnatprod.5c01455
摘要
Nine novel dihydro-α-pyrone derivatives, talaromypyrones A–I ( 1 – 9 ), were isolated from the soil-derived fungus Talaromyces sp. G23. These compounds share a conserved 3′ R -configuration within the 4-hydroxy-5,6-dihydro-2-pyrone core but display notable variations in their flanking polyketide chains. Talaromypyrones A–H ( 1 – 8 ) demonstrate potent antibacterial activity against Gram-positive bacteria, including drug-resistant strains, while exhibiting excellent safety profile by showing no cytotoxicity toward normal human LO2 cells. However, they exhibit no activity against Gram-negative bacteria (likely due to their inability to penetrate the outer membrane) and fungi. Such antimicrobial profile, combined with the structural similarity to the α-pyrone antibiotic myxopyronin, suggests a potential target in the switch region of bacterial RNA polymerase (RNAP). Molecular docking studies revealed that talaromypyrone E ( 5 ) binds to the same site of RNAP as myxopyronin and forms additional hydrogen bonds between the 4-hydroxy-5,6-dihydro-2-pyrone core and the RNAP residues. Furthermore, talaromypyrones A ( 1 ) and D ( 4 ) demonstrate moderate anti-inflammatory activity, positioning 4-hydroxy-5,6-dihydro-2-pyrone core as a promising building block for the development of dual-function agents capable of concurrently addressing both conventional and drug-resistant bacterial infections while alleviating associated inflammatory responses.
科研通智能强力驱动
Strongly Powered by AbleSci AI